Dark

CALT
Calliditas Therapeutics AB
stock NASDAQ

Inactive

Sep 20, 2024

40.00USD-0.398%(-0.16)9,796

Pre-market

0.00USD-100.000%(-40.16)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsMore

open chart

Headquarters

Stockholm, Sweden

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Profile

Calliditas is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

.dark-mode .v4Hqlm{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .v4Hqlm{ color: #333333; background-color: white; border: 2px solid #333333; }CALTCalliditas Therapeutics ABstock NASDAQ

CALT
Calliditas Therapeutics AB
stock NASDAQ